PH25497A - Method of treating diseases with certain geminal diphosphonates - Google Patents

Method of treating diseases with certain geminal diphosphonates

Info

Publication number
PH25497A
PH25497A PH34598A PH34598A PH25497A PH 25497 A PH25497 A PH 25497A PH 34598 A PH34598 A PH 34598A PH 34598 A PH34598 A PH 34598A PH 25497 A PH25497 A PH 25497A
Authority
PH
Philippines
Prior art keywords
certain
treating diseases
geminal diphosphonates
diphosphonates
geminal
Prior art date
Application number
PH34598A
Other languages
English (en)
Inventor
James John Benedict
Christopher Mark Perkins
Original Assignee
James John Benedict
Christopher Mark Perkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James John Benedict, Christopher Mark Perkins filed Critical James John Benedict
Publication of PH25497A publication Critical patent/PH25497A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH34598A 1985-12-13 1986-12-15 Method of treating diseases with certain geminal diphosphonates PH25497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/808,584 US4902679A (en) 1985-12-13 1985-12-13 Methods of treating diseases with certain geminal diphosphonates

Publications (1)

Publication Number Publication Date
PH25497A true PH25497A (en) 1991-07-24

Family

ID=25199180

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34598A PH25497A (en) 1985-12-13 1986-12-15 Method of treating diseases with certain geminal diphosphonates

Country Status (6)

Country Link
US (1) US4902679A (de)
EP (1) EP0230068B1 (de)
JP (1) JPH07116047B2 (de)
DE (1) DE3686038T2 (de)
IE (1) IE59593B1 (de)
PH (1) PH25497A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83657C (fi) * 1989-09-08 1991-08-12 Huhtamaeki Oy Foerfarande foer framstaellning av metylenbisfosfonsyror.
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
DE69116838T2 (de) * 1990-12-19 1996-06-13 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung
DE69225325T2 (de) * 1991-09-05 1998-08-27 Toray Industries Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
PL175046B1 (pl) * 1992-05-29 1998-10-30 Procter & Gamble Pharma Nowe tio-podstawione, zawierające azot heterocykliczne związki fosfonianowe
CA2188066C (en) * 1992-05-29 2000-12-05 Susan Mary Kaas Thio-substituted phosphonate compounds
ES2155446T3 (es) * 1992-07-10 2001-05-16 Toray Industries Derivado de metanodifosfonato, su produccion y su uso farmaceutico.
DE4228552A1 (de) * 1992-08-27 1994-03-03 Boehringer Mannheim Gmbh Diphosphonsäuren und deren Salze enthaltende Arzneimittel
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
AU761267C (en) 1998-09-09 2007-08-09 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US20020128680A1 (en) * 2001-01-25 2002-09-12 Pavlovic Jennifer L. Distal protection device with electrospun polymer fiber matrix
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085321B1 (de) * 1982-01-27 1986-08-27 Schering Aktiengesellschaft Diphosphonsäure-Derivate und diese enthaltende pharmazeutische Präparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
FR2558837B1 (fr) * 1984-01-26 1986-06-27 Sanofi Sa Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism

Also Published As

Publication number Publication date
EP0230068B1 (de) 1992-07-15
DE3686038T2 (de) 1993-01-07
IE863260L (en) 1987-06-13
EP0230068A2 (de) 1987-07-29
DE3686038D1 (de) 1992-08-20
IE59593B1 (en) 1994-03-09
JPS62265228A (ja) 1987-11-18
EP0230068A3 (en) 1988-06-22
JPH07116047B2 (ja) 1995-12-13
US4902679A (en) 1990-02-20

Similar Documents

Publication Publication Date Title
DE3571836D1 (en) Method of surface treatment
PH25497A (en) Method of treating diseases with certain geminal diphosphonates
GB8704089D0 (en) Method of treatment
GB8409960D0 (en) Therapeutic method
GB8615963D0 (en) Method of heating
HK91494A (en) Method of treating fluids
EP0149519A3 (en) Method of treating heart disease
PH24943A (en) Method of treating hepatitis
GB8512143D0 (en) Method of treatment
GB8414020D0 (en) Method of treatment
GB8513981D0 (en) Method of treatment
GB8507004D0 (en) Method of treatment
SU1374491A1 (ru) Cпocoб пoлучehия диaгhoctиkуma
BG38836A1 (en) Method for treatment of phospogypsum
ZA857722B (en) Process for treatment of diseases
GB8809586D0 (en) Method of treating urine
ZA85125B (en) Method of treating heart disease
GB8402572D0 (en) Biological treatment method
SU1367190A1 (ru) Cпocoб лeчehия гohaptpoзa
PH24147A (en) Method of treating functional hallux limitus
CS811987A1 (en) Method of pitches treatment
BG45889A1 (en) Method for electroisolational final treatment of surfaces with complicated profile
CS90185A1 (en) Method for surface treatment of lighting fitting montures
GB8704090D0 (en) Method of treatment
GB8718025D0 (en) Method of treatment